Evidence map›Paper›PMID 35474604›Full record

ArticleThoracic cancer2022

Activation of circ_0072088/miR-1261/PIK3CA pathway accelerates lung adenocarcinoma progression.

Feng Cao, Sihua Liu, Ziyi Li, Lingjiao Meng, Meixiang Sang, Baoen Shan

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Feng CaoDepartment of Radiation Oncology, the Fourth Hospital of HebeiMedical University, Shijiazhuang, China.ORCID 0000-0003-1604-1723
Sihua LiuResearch Center, the Fourth Hospital of HebeiMedical University, Shijiazhuang, China.
Ziyi LiResearch Center, the Fourth Hospital of HebeiMedical University, Shijiazhuang, China.
Lingjiao MengResearch Center, the Fourth Hospital of HebeiMedical University, Shijiazhuang, China.
Meixiang SangResearch Center, the Fourth Hospital of HebeiMedical University, Shijiazhuang, China.
Baoen ShanResearch Center, the Fourth Hospital of HebeiMedical University, Shijiazhuang, China.ORCID 0000-0003-4775-104X
Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) are involved in the tumorigenesis and progression of lung adenocarcinoma (LUAD). This study aimed to determine the role of circ_0072088 in LUAD.

methodsThe existence and expression of circ_0072088 in human LUAD tissues and cell lines were determined through Sanger sequencing, quantitative reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization (FISH). Subsequently, the biological role of circ_0072088 was examined using loss-of-function assays in H1299 cells. Moreover, circ_0072088/miR-1261/PIK3CA pathway-mediated biological effects in H1299 were verified using bioinformatic prediction and experiments, including interaction analysis (FISH, luciferase reporter, and RNA-pulldown assays), and tumor biological function test (CCK8 and colony formation, wound healing, and transwell assays). Finally, miR-1261 and PIK3CA expression and LUAD patient survival were further analyzed using FISH, immunohistochemical staining, and the Kaplan-Meier plotter database, respectively.

resultsFirst, an increase in circ_0072088 was confirmed in human LUAD tissues. Thereafter, it was mainly localized in the cytoplasm and was found to enhance cell proliferation, migration, and invasion of H1299 cells. Mechanistically, circ_0072088 directly downregulated miR-1261 expression, whereas increased PIK3CA gene expression was associated with poor overall survival of LUAD patients. The activation of the circ_0072088/miR-1261/PIK3CA regulatory pathway may play a significant role in the tumorigenesis and progression of LUAD.

conclusionsCirc_0072088-dependent regulation of miR-1261/PIK3CA is important for cell proliferation, migration, and invasion during the tumorigenesis and progression of LUAD, warranting the need to consider the circ_0072088/miR-1261/PIK3CA regulatory pathway as a potential therapeutic target in patients with lung adenocarcinoma.

Indexed as

Adenocarcinoma of LungClass I Phosphatidylinositol 3-KinasesLung NeoplasmsMicroRNAsRNA, CircularCarcinogenesisCell Line, TumorCell ProliferationDisease ProgressionHumansIn Situ Hybridization, FluorescenceSignal TransductionClass I Phosphatidylinositol 3-KinasesMicroRNAsPIK3CA protein, humanRNA, Circularbioinformaticscell linescircRNAslung adenocarcinomatumorigenesis

Identifiers

PMID35474604
PMCPMC9161339
OpenAlexW4224938574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.